Twist-ing cell fate: Mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis

Journal of Cellular Biochemistry

Volumn 110, Issue 6, 2010, Pages 1288-1298

  Cakouros, D ^a,b   Raices, R M ^c   Gronthos, S ^a,b   Glackin, C A ^c  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adipocytes; BMP; Cancer stem cells; Chondrocyte; MSC; Osteoblast; Smad; TGF ; Twist; Wnt

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DNA; HETERODIMER;

CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL SPECIFICITY; MESENCHYMAL STEM CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; MULTIPOTENT STEM CELLS; NEOPLASTIC STEM CELLS; TWIST TRANSCRIPTION FACTOR;

EID: 77955484344     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22651     Document Type: Review

References (144)

1. Aboody KS, Najbauer J, Danks MK. 2008. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 15:739-752.
2. Agiostratidou G, Hulit J, Phillips GR, Hazan RB. 2007. Differential cadherin expression: Potential markers for epithelial to mesenchymal transformation during tumor progression. J Mammary Gland Biol Neoplasia 12:127-133.
3. Akiyama T. 2000. Wnt/beta-catenin signaling [in process citation]. Cytokine Growth Factor Rev 11:273-282.
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988. (Pubitemid 36418143)
5. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A. 2008. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14:79-89.
6. Balint E, Lapointe D, Drissi H, van der Meijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2003. Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP-2-mediated osteo-blast differentiation. J Cell Biochem 89:401-426.
7. Baum B, Settleman J, Quinlan MP. 2008. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19:294-308.
8. Behrens J. 2000. Cross-regulation of the Wnt signalling pathway: A role of MAP kinases. J Cell Sci 113:911-919.
9. Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz D, Olson E, Justice M, Karsenty G. 2004. A Twist code determines the onset of osteoblast differentiation. Dev Cell 6:423-435.
10. Biere B, Moses H. 2006. TGFbeta: The molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6:506-520.
11. Boland G, Perkins G, Hall D, Tuan R. 2004. Wnt3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93:1210-1230.
12. Bourgeois P, Bolcato-Bellemin A, Danse J, Bloch-Zupan A, Yoshiba K, Stoetzel C, Perrin-Schmitt F. 1998. The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum Mol Genet 7:945-957.
13. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. 2005. Opinion: Migrating cancer stem cells - An integrated concept of malignant tumour progression. Nat Rev Cancer 5:744-749.
14. Cariati M, Purushotham AD. 2008. Stem cells and breast cancer. Histopathology 52:99-107.
15. Castanon I, Stetina SV, Kass J, Baylies M. 2001. Dimerisation partners determine the activity of the Twist bHLH protein during Drosophila mesoderm development. Development 128:3145-3159.
16. Chen Q, Johnson D, Haudenschild D, Goetinck P. 1995. Cartilage matrix protein forms a type II collagen independent filamentous network: Analysis in primary cell cultures with a retrovirus expression system. Mol Biol Cell 6:1743-1753.
17. Chen Y, Whetsone H, Youn A, Nadesan P, Chow E, Lin A, Alman B. 2007. Beta-catenin signaling is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 282:526-533.
18. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. 2007. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67:1979-1987.
19. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. 2006. Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344.
20. Connerney J, Andreeva V, Leshem Y, Muentener C, Mercado M, Spicer D. 2006. Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn 235:1345-1357.
21. Connerney J, Andreeva V, Lesham Y, Mercado M, Dowell K, Yang X, Lindner V, Friesel R, Spicer D. 2008. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol 318:323-334.
22. Corsi A, Brodigan T, Jorgensen E, Krause M. 2002. Characterisation of a dominant negative C. elegans Twist mutant protein with implications for human Saethre-Chotzen syndrome. Development 129:2761-2772.
23. Cunningham M, Seto M, Ratisoontorn C, Heike C, Hing A. 2007. Syndromic craniosynostosis: From history to hydrogen bonds. Orthod Craniofac Res 10:67-81.
24. Day T, Guo X, Beal LG, Yang Y. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750.
25. Denef N, Neubuser D, Perez L, Cohen S. 2000. Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened. Cell 102:521-531.
26. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [see comments]. Cell 89:747-754.
27. Dvorak HF. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659.
28. Eastman Q, Grosschedl R. 1999. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11:233-240.
29. el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A, Bonaventure J. 1997 .Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15:42-46.
30. Fang MA, Glackin CA, Sadhu A, McDougall S. 2001. Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells. J Cell Biochem 80:550-559.
31. Fata JE, Werb Z, Bissell MJ. 2004. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6:1-11.
32. Firulli A, Conway S. 2008. Phosphoregulation of Twist1 provides a mechanism of cell fate control. Curr Med Chem 15:2641-2647.
33. Firulli B, Krawchuk D, Centoze V, Virshup D, Conway S, Cserjesi P, Laufer E, Firulli A. 2005. Altered Twist1 and hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities. Nat Genet 37:373-381.
34. Fischer L, Boland G, Tuan R. 2002a. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 277:30870-30878.
35. Fischer L, Boland G, Tuan RS. 2002b. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem 84:816-831.
36. Galler K, Yasue A, Cavendar A, Bialek P, Karsenty G, D'Souza R. 2007. A novel role for Twist-1 in pulp homeostasis. J Dent Res 86:951-955.
37. Gammill LS, Bronner-Fraser M. 2003. Neural crest specification: Migrating into genomics. Nat Rev Neurosci 4:795-805.
38. Gavert N, Ben-Ze'ev A. 2008. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14:199-209.
39. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P. 1999. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112(Pt 24): 4615-4625.
40. Gong X, Li L. 2002. Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction and chromatin deacetylation. J Biol Chem 277:12310-12317.
41. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato A, Wang H, Cundy T, Glorieux F, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins W, Allgrove J, Arslan-Kirchner M, Batch J, Beighton P, Black G, Boles R, Boon L, Borrone C, Brunner H, Carle G, Dallapiccola B, Paepe AD, Floege B, Halfhide M, Hall B, Hennekam R, Hirose T, Jans A, Juppner H, Kim C, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar R, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, Boogaard MVD, Hul WV, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen B, Warman M. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
42. Gripp KW, Zackai EH, Stolle CA. 2000. Mutations in the human TWIST gene. Hum Mutat 15:479.
43. Gronthos S, Zannettino A, Hay S. 2003a. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
44. Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. 2003b. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
45. Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White D, Rubin C. 2002. Transcriptional profiling of bone regenration. Insight into the molecular complexity of wound repair. J Biol Chem 277:30177-30182.
46. Hamamori Y, Wu H, Sartorelli V, Kedes L. 1997. The basic domain of myogenic basichelic-loop-helix (bHLH) proteins is thenovel target for direct inhibition by another bHLH protein, Twist. Mol Cell Biol 17:6563-6573.
47. Harris SE, Guo D, Harris MA, Krishnaswamy A, Lichtler A. 2003. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: Role of Dlx2 and Dlx5 transcription factors. Front Biosci 8:s1249-s1265.
48. Hartikka H, Makitie O, Mannikko M, Doria A, Daneman A, Cole W, Alakokko L, Sochett E. 2005. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 20:783-789.
49. Hartmann C, Tabin C. 2001. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104:341-351.
50. Hay ED. 1995. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154:8-20.
51. Hayashi M, Nimura K, Kashiwagi K, Harada T, Takaoka K, Kato H, Tamai K, Kaneda Y. 2007. Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling. J Cell Sci 120:1350-1357.
52. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB. 2009. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116-4124.
53. Hilton M, Tu X, Cook J, Hu H, Long F. 2005. Ihh controls cartilage development by antagonizing Gli3 but requires additional effectors to regulate osteoblast and vascular development. Development 132:1971-1979.
54. Holleville N, Mateos S, Bontoux M, Bollerot K, Monsoro-Burq A. 2007. Dlx5 drives Runx2 expression and osteogenic differentiation in developing cranial suture mesenchyme. Dev Biol 304:860-874.
55. Howard T, Paznekas W, Green E, Chiang L, Ma N, Luna ROD, Delgado CG, Ramos MG, Kline A, Jabs E. 1997. Mutations in Twist, a basic helix-loophelix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 15: 36-41.
56. Hui C, Joyner A. 1993. A mouse model of Greig cephalopolysyndactyly syndrome: The extra toes mutation contains an intragenic deletion of the Gli3 gene. Nat Genet 3:241-246.
57. Hurt EM, Farrar WL. 2008. Cancer stem cells: The seeds of metastasis? Mol Interv 8:140-142.
58. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. 1998. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17:1371-1384.
59. Inoue S, Urano T, Ogawa S, Saito T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M. 1999. Molecular cloning of rat EFP: Expression and regulation in primary osteoblasts. Biochem Biophys Res Commun 261:412-418.
60. Isenmann S, Arthur A, Zannettino A, Turner J, Shi S, Glackin C, Gronthos S. 2009. Twist family of basic-helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 27:2457-2468.
61. Ishii M, Merrill AE, Chan YS, Gitelman I, Rice DP, Sucov HM, Maxson RE, Jr. 2003. Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 130:6131-6142.
62. Jabs E. 2004. Twist and the Saethre-Chotzen syndrome. New York: Oxford University Press.
63. Jechlinger M, Grunert S, Tamir IH, Janda E, Ludemann S, Waerner T, Seither P, Weith A, Beug H, Kraut N. 2003. Expression profiling of epithelial plasticity in tumor progression. Oncogene 22:7155-7169.
64. Johnson D, Horsley SW, Moloney DM, Oldridge M, Twigg SR, Walsh S, Barrow M, Njolstad PR, Kunz J, Ashworth GJ, Wall SA, Kearney L, Wilkie AO. 1998. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am J Hum Genet 63:1282-1293.
65. Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, Kikkawa F. 2007. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 31:277-283.
66. Kalluri R, Neilson EG. 2003. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784.
67. Kang K, Hatano B, Lee CH. 2007. PPAR delta agonists and metabolic diseases. Curr Atheroscler Rep 9:72-77.
68. Karsenty G, Wagner E. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406.
69. Kengaku M, Capdevila J, Rodriguez-Esteban C, De La Pena J, Johnson RL, Belmonte JCI, Tabin CJ. 1998. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 280: 1274-1277.
70. Kim J, Leucht P, Lam K, Luppen C, Berge DT, Nusse R, Helms J. 2007. Bone regeneration is regulated by Wnt signaling. J Bone Miner Res 22:1913-1923.
71. Kitagaki J, Iwamoto M, Liu J, Tamamura Y, Pacifci M, Enomoto-Iwamoto M. 2003. Activation of beta-catenin-LEF/TCF signal pathway in chondrocytes stimulates ectopic endochondral ossification. Osteoarthritis Cartilage 11: 36-43.
72. Kleer CG, Zhang Y, Merajver SD. 2007. CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer. Cells Tissues Organs 185:95-99.
73. Koebernick K, Pieler T. 2002. Gli-type zinc finger proteins as bipotential transducers of Hedgehog signaling. Differentiation 70:69-76.
74. Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M. 2007. Vimentin and epithelial-mesenchymal transition in human breast cancer - Observations in vitro and in vivo. Cells Tissues Organs 185:191-203.
75. Komaki M, Karakida T, Abe M, Oida S, Mimori K, Iwasaki K, Noguchi K, Oda S, Ishikawa I. 2007. Twist negatively regulates osteoblastic differentiation in human periodontal ligament cells. J Cell Biochem 100:303-314.
76. Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA. 1999. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 75:566-577.
77. Lee YS, Lee HH, Park J, Yoo EJ, Glackin CA, Choi YI, Jeon SH, Seong RH, Park SD, Kim JB. 2003. Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c. Nucleic Acids Res 31:7165-7174.
78. Leptin M. 1991. Twist and snail as positive and negative regulators during Drosophila mesoderm development. Genes Dev 5:1568-1576.
79. Li F, Tiede B, Massague J, Kang Y. 2007. Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res 17:3-14.
80. Li TS, Komota T, Ohshima M, Qin SL, Kubo M, Ueda K, Hamano K. 2008. TGF-beta induces the differentiation of bone marrow stem cells into immature cardiomyocytes. Biochem Biophys Res Commun 366:1074-1080.
81. Liao MJ, Zhang CC, Zhou B, Zimonjic DB, Mani SA, Kaba M, Gifford A, Reinhardt F, Popescu NC, Guo W, Eaton EN, Lodish HF, Weinberg RA. 2007. Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res 67:8131-8138.
82. Lien HC, Hsiao YH, Lin YS, Yao YT, Juan HF, Kuo WH, Hung MC, Chang KJ, Hsieh FJ. 2007. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: Identification of genes potentially related to epithelial-mesenchymal transition. Oncogene 26:7859-7871.
83. Lin J, Handschin C, Spiegelman B. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 3:429-438.
84. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF. 2007. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217-226.
85. Lobo NA, Shimono Y, Qian D, Clarke MF. 2007. The biology of cancer stem cells. Annu Rev Cell Dev Biol 23:675-699.
86. Locklin RM, Oreffo RO, Triffitt JT. 1998. Modulation of osteogenic differentiation in human skeletal cells in vitro by 5-azacytidine. Cell Biol Int 22:207-215.
87. Long M, Robinson J, Ashcraft E, Mann K. 1995. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 95:881-887.
88. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
89. Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
90. Massague J. 2008. TGFbeta in Cancer. Cell 134:215-230.
91. Massari M, Murre C. 2000. Helix-loop-helix proteins: Regulators of transcription in eukaryotic organisms. Mol Cell Biol 20:429-440.
92. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS. 1996. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: Role of Fra-2 and Jun D during differentiation. Endocrinology 137:4398-4408.
93. Mironchik Y, Winnard PT, Jr., Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V. 2005. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 65: 10801-10809.
94. Mo R. 1997. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124:113-123.
95. Moon R, Bowerman B, Boutros M, Perrimon N. 2002. The promise and perils of Wnt signaling through beta-catenin. Science 296:1644-1646.
96. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. 2008. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3:e2888.
97. Moustakas A, Heldin CH. 2007. Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98:1512-1520.
98. Nakamura T, Hanada K, Tamura M, Shibanushi T, Nigi H, Tagawa M, Fukomoto S, Matsumoto T. 1995. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136:1276-1284.
99. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
100. O'Rourke M, Tam P. 2002. Twist functions in mouse development. Int J Dev Biol 46:401-413.
101. Pan D, Fujimoto M, Lopes A, Wang Y. 2009. Twist1 is a PPARd-inducible, negative-feedback regulator of PGC-1a in brown fat metabolism. Cell 137: 73-86.
102. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
103. Reardon W, Winter RM. 1994. Saethre-Chotzen syndrome. J Med Genet 31:393-396.
104. Reinhold MI, Kapadia RM, Liao Z, Naski MC. 2006. The Wnt-inducible transcription factor Twist1 inhibits chondrogenesis. J Biol Chem 281:1381-1388.
105. Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
106. Ryoo H, Lee M, Kim Y. 2006. Critical molecular switches involved in BMP-2 induced osteogenic differentiation of mesenchymal cells. Genes Dev 366: 51-57.
107. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C. 2008. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11:123-151.
108. Salazar VS, Mbalaviele G, Civitelli R. 2008. The pro-osteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity. J Cell Biochem 104:942-952.
109. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC, Manjili MH, Radisky DC, Ferrone S, Knutson KL. 2009. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69:2887-2895.
110. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. 2008. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68:989-997.
111. Savagner P, Boyer B, Valles AM, Jouanneau J, Thiery JP. 1994. Modulations of the epithelial phenotype during embryogenesis and cancer progression. Cancer Treat Res 71:229-249.
112. Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T, Hudson LG. 2005. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 202:858-866.
113. Seto E, Bellen H. 2004. The ins and outs of Wingless signaling. Trends Cell Biol 14:45-53.
114. Shah R, Alvarez M, Jones DR, Torrungruang K, Watt AJ, Selvamurugan N, Partridge NC, Quinn CO, Pavalko FM, Rhodes SJ, Bidwell JP. 2004. Nmp4/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts. Am J Physiol Endocrinol Metab 287:E289-E296.
115. Shalhoub V, Gerstenfeld LC, Collart D, Lian JB, Stein GS. 1989. Downregulation of cell growth and cell cycle regulated genes during chick osteoblast differentiation with the reciprocal expression of histone gene variants. Biochemistry 28:5318-5322.
116. Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS, Lian JB. 1992. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem 50:425-440.
117. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R, Jr., Badve S, Nakshatri H. 2006. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res 8:R59.
118. Shimoyama A, Wada M, Ikeda F, Hato K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R, Yoneda T. 2007. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18:2411-2418.
119. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K. 2007. Molecular definition of breast tumor heterogeneity. Cancer Cell 11:259-273.
120. Shook D, Keller R. 2003. Mechanisms, mechanics and function of epithelialmesenchymal transitions in early development. Mech Dev 120:1351-1383.
121. Simpson P. 1983. Maternal-zygotic gene interactions during formation of dorsoventral pattern in Drosophila embryos. Genetics 105:615-632.
122. Sommers CL, Heckford SE, Skerker JM, Worland P, Torri JA, Thompson EW, Byers SW, Gelmann EP. 1992. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res 52:5190-5197.
123. Spicer D, Rhee J, Cheung W, Lassar A. 1996. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science 272: 1476-1480.
124. Stingl J, Caldas C. 2007. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7:791-799.
125. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. 2006. Purification and unique properties of mammary epithelial stem cells. Nature 439:993-997.
126. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
127. Thiery JP. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746.
128. Thiery JP, Chopin D. 1999. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18:31-42.
129. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME. Martin GR. Dickson RB. 1992. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534-544.
130. Turley EA, Veiseh M, Radisky DC, Bissell MJ. 2008. Mechanisms of disease: Epithelial-mesenchymal transition - Does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 5:280-290.
131. Verrecchia F, Mauviel A. 2002. Control of connective tissue gene expression by TGF beta: Role of smad proteins in fibrosis. Curr Rheumatol Rep 4:143-149.
132. Vesuna F, Lisok A, Kimble B, Raman V. 2009. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11: 1318-1328.
133. Warren S, Brunet L, Harland R, Economides A, Longaker M. 2003. The BMP antagonist noggin regulates cranial suture fusion. Nature 422:625-629.
134. Weigelt B, Kreike B, Reis-Filho JS. 2009. Metaplastic breast carcinomas are basal-like breast cancers: A genomic profiling analysis. Breast Cancer Res Treat 117:273-280.
135. Westendorf J, Kahler R, Schroeder T. 2004. Wnt signaling in osteoblasts and bone diseases. Genes Dev 341:19-39.
136. Wolf C, Thisse C, Stoetzel C, Thisse B, Gerlinger P, Perrin-Schmitt F. 1991. The M-twist gene of Mus is expressed in subsets of mesodermal cells and is closely related to the Xenopus X-twi and the Drosophila twist genes. Dev Biol 143:363-373.
137. Wozney J, Rosen V. 1998. Bone morphogenetic protein and bone morphogenetic protein family in bone formation and repair. Clinic Orthop Relat Res 1998:26-37.
138. Yang J, Weinberg RA. 2008. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14:818-829.
139. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939.
140. Yousfi M, Lasmoles F, Lomri A, Delannoy P, Marie P. 2001. Increased bone formation and decreased osteoclacin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest 107:1153-1161.
141. Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG. 2005. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res 7:R1080-R1089.
142. Zhong N, Gersch R, Hadjiargyrou M. 2006. Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone 39:5-16.
143. Zhou S, Eid K, Glowacki J. 2004. Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J Bone Miner Res 19:463-470.
144. Zhuo WL, Wang Y, Zhuo XL, Zhang YS, Chen ZT. 2008. Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway. Biochem Biophys Res Commun 369:1098-1102.